-17.95 (-1.09%) The Exchange has sought clarification from Sun Pharmaceutical Industries on September 07, 2018 with reference to news appeared on: www.moneycontrol.com dated September 07, 2018 quoting ‘Sun Pharma falls 5% on report of co getting 6 observations by US FDA for Halol unit’.
The above information is a part of company’s filings submitted to BSE.